Canada markets closed

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1800+0.0200 (+1.72%)
At close: 04:00PM EDT
1.1884 +0.01 (+0.71%)
After hours: 06:49PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
32,015
31,249
29,752
6,761
6,482
Cost of Revenue
18,369
18,081
11,960
4,713
5,133
Gross Profit
13,646
13,168
17,792
2,048
1,349
Operating Expenses
Research Development
69,126
98,384
77,813
43,813
29,338
Selling General and Administrative
26,608
31,098
25,133
23,619
20,530
Total Operating Expenses
95,734
129,482
102,946
67,432
49,868
Operating Income or Loss
-82,088
-116,314
-85,154
-65,384
-48,519
Total Other Income/Expenses Net
23,042
27,466
-1,754
-25,481
-2,817
Income Before Tax
-59,046
-88,848
-86,908
-90,865
-51,336
Income Tax Expense
-
-367
0
0
-182
Income from Continuing Operations
-58,679
-88,481
-86,908
-90,865
-51,154
Net Income
-58,679
-88,481
-86,908
-90,865
-51,015
Net Income available to common shareholders
-58,679
-88,481
-86,908
-90,865
-51,015
Basic EPS
-1.66
-1.27
-1.33
-1.60
-1.20
Diluted EPS
-1.66
-1.27
-1.33
-1.60
-1.20
Basic Average Shares
68,765
69,809
65,214
56,731
42,539
Diluted Average Shares
68,765
69,809
65,214
56,731
42,539